What influences the chances of recovery negatively? | What are the chances of cure for prostate cancer?

What influences the chances of recovery negatively?

The chances of recovery are generally negatively influenced by a large and advanced tumor of the prostate. In detail, this means that a prostate cancer that occupies large parts of the prostate, may already be growing outside the prostate and may have metastases in the body, has a lower chance of cure. A further factor that negatively influences the chances of a cure for prostate cancer is the presence of strongly altered cancer cells.

They are often aggressive, therefore fast-growing and are more likely to spread throughout the body than slightly altered cancer cells. A high patient age is also one of the more negatively influencing chances of a cure. This is also because in this case it is not a cure but a slowing down of the spread of the cancer that makes more sense as a therapeutic goal.

What positively influences the chances of recovery?

The chances of cure are thus positively influenced by a low level of prostate cancer tumor stage, contrary to the above. This includes a small tumor that grows inside the organ, has no cells in the adjacent tissue outside or further away in the body and is only slightly changed in contrast to healthy tissue. It is therefore only slightly aggressive and easy to treat.

In addition, a low patient age often has a positive effect on the chances of recovery. It has also been shown that a diet rich in tomatoes has a positive influence on the chances of recovery. The most decisive and therefore most important factor, however, is probably to use a targeted therapy against prostate cancer.

This includes the complete surgical removal of the affected prostate, including any lymph nodes that may be affected. Radiation therapy is also often used to kill cancer cells remaining in the body. It is sometimes administered in combination with hormone therapy. Also, the preventive medical checkup leads to better chances by early detection of prostate cancer.